Skip to main content
Vineet Laboratories Limited logo

Vineet Laboratories Limited — Investor Relations & Filings

Ticker · VINEETLAB ISIN · INE505Y01010 LEI · 98450053FEE2D64C6147 BSE.NS Manufacturing
Filings indexed 276 across all filing types
Latest filing 2025-10-13 Regulatory Filings
Country IN India
Listing BSE.NS VINEETLAB

About Vineet Laboratories Limited

http://vineetlabs.co.in/

Vineet Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and API intermediates. The company focuses on producing high-quality chemical compounds through advanced research and development, catering to diverse therapeutic segments including anti-retroviral, anti-diabetic, and anti-hypertensive treatments. Its core operations involve the synthesis of complex molecules and fine chemicals, supported by manufacturing facilities that adhere to rigorous quality management systems. Vineet Laboratories provides custom synthesis and contract manufacturing services, positioning itself as a technical partner for global healthcare organizations. The company emphasizes process optimization and cost-effective production to deliver reliable chemical solutions for large-scale pharmaceutical applications.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-10-13 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the scheduling of a Board Meeting to consider and approve unaudited standalone financial results for the second quarter and half year ended September 30, 2025. It also mentions the closure of the trading window in compliance with SEBI regulations. The document does not contain the financial results themselves but is an announcement of the upcoming board meeting where such results will be approved. The document length is short (1687 characters) and serves as an intimation rather than a report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations, not the actual Interim/Quarterly Report (IR).
2025-10-13 English
Updates
Regulatory Filings
2025-10-04 English
Trading Window
Regulatory Filings
2025-09-30 English
Updates
Regulatory Filings
2025-09-29 English
Shareholders meeting
Regulatory Filings
2025-09-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.